Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
Xcellon Biologics, a Maryland CRDMO specializing in bioconjugates and complex biologics, has signed a definitive agreement to acquire the GMP biologics manufacturing facility built by NextCure, Inc. in Beltsville. The deal gives Xcellon its first cGMP capacity, completes the company’s transition from a development-stage CDMO into an end-to-end CRDMO, and puts a commissioned domestic bioconjugation […]
Read More →Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]
Velocity Clinical Research has appointed Justin Starzyk as Chief Executive Officer, succeeding Paul Evans, who is transitioning to Chair of the Board. “Leading Velocity has been the privilege of my career. Together, we built the world’s leading integrated site organization, and I’m proud of what this team has accomplished for patients, sponsors, and sites,” Evans […]
Kincell Bio, a cell therapy contract development and manufacturing organization (CDMO) with a Research Triangle Park facility, announced on September 17, 2026 that it completed a merger with Cellipont Bioservices, based in The Woodlands, Texas, to form Kincellis Advanced Therapies, a scaled U.S.-based CDMO for advanced-therapy developers. CEO Darren Head said: “Kincell and Cellipont are […]
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]
Actuated Medical, Inc., of Bellefonte, Pennsylvania, has been named the winner of the 2026 BioHealth Capital Region Crab Trap Competition, following a live pitch on September 16 at U.S. Pharmacopeia in Rockville, Maryland, during BioHealth Capital Region Week. Maureen L. Mulvihill, PhD, President, CEO, and Co-Founder of Actuated Medical, presented the company’s NeuralGlider® platform, a […]
Kemp Proteins, LLC, a Frederick, Maryland-based gene-to-protein services provider, announced on September 17, 2026 a strategic partnership with NeuImmune to implement NeuImmune’s proprietary glycoengineered CHO (geCHO) BioDesign platform, giving Kemp greater control over protein glycosylation in its cell line development and recombinant protein production work. “The geCHO platform provides greater control over glycosylation and its […]
University of North Carolina (UNC) Lineberger Comprehensive Cancer Center has received $40 million from the OpenAI Foundation — the nonprofit parent organization that governs the for-profit OpenAI Group PBC — to generate data aimed at making personalized cancer vaccines more effective, the Chapel Hill, North Carolina-based cancer center announced September 15, 2026. Immunologist Benjamin Vincent, […]
Claritev has appointed Ben Letham to its Board of Directors, effective September 14, 2026. “Claritev is fortunate to add a visionary of Ben’s stature to our Board. Over the past two years, we have transformed our leadership, Board, and solution strategy to position Claritev for its next phase of growth,” said Travis Dalton, CEO and […]
Georgiamune, a Gaithersburg, Maryland-based clinical-stage biotech with roughly 30 employees, has raised approximately $92.69 million in Series B financing to advance its cancer and autoimmune disease programs, with Prevail Private Capital and Mubadala Capital leading the round. A Large Round, Structured in Two Tranches The Series B was structured across B1 and B2 tranches and […]
